We are excited to welcome new Bio Nebraska member, Aeolian Biotech.
Aeolian Biotech was founded in 2022 and is developing an improved vaccine against Streptococcus pneumoniae (Sp), a major cause of serious infection in older adults. The current vaccines are effective against the serotypes of Sp included in their vaccines, but their vaccines only include half the disease causing serotypes in the US. Aeolian’s composition, protected by a US patent, will provide coverage against 95%. Their team includes vaccine development experts including senior executives from the team at Wyeth/Pfizer who developed the market leading vaccine for Sp, Prevnar. The company headquarters is in Lincoln, Nebraska.